Pancreatic cell transplant for type 1 diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a new treatment using pancreatic cells that may help people with type 1 diabetes make insulin again. It aims to reduce severe low blood sugar episodes and improve blood sugar control.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have type 1 diabetes diagnosed before age 40.
- You have needed insulin for at least 5 years.
- You have had severe low blood sugar (hypoglycemia) episodes.
- You are willing to use a continuous glucose monitor (a device that checks your sugar levels).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new treatment made from pig pancreatic cells (called OPF-310) that are placed under the skin to help control blood sugar in people with type 1 diabetes. It is for those whose diabetes is difficult to manage and who have dangerous low blood sugar episodes.
This trial tests whether transplanting your own insulin-making cells (islets) can help control blood sugar if you have type 2 diabetes and your pancreas is not making enough insulin. The goal is to reduce or stop your need for insulin injections.
This trial studies whether transplanting insulin-producing islet cells can improve blood sugar control and reduce severe low blood sugar in people with “brittle” type 1 diabetes. It’s meant for adults with long-standing insulin dependence and troublesome, hard-to-control hypoglycemia.
This trial tests whether transplanting stem cells that can turn into insulin-producing cells helps people with type 1 diabetes manage their blood sugar. It may reduce the need for insulin injections.
This Phase 1 study tests a new immune-system strategy around islet transplantation (or donor bone marrow therapy) to improve control of type 1 diabetes and reduce dangerous low blood sugar. It mainly aims to see if the approach is safe and helpful in people with long-standing, difficult-to-manage diabetes.
This trial tests whether transplanting insulin-producing “islet” cells can better control blood sugar in people who have already received a kidney transplant. It’s mainly for adults with type 1 diabetes whose body is no longer making enough insulin, while they are on kidney-transplant medicines.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.